SNDX-5613
Product Specifications
CAS Number
2169919-21-3
Target
Histone Methyltransferase|||Epigenetic Reader Domain
Related Pathways
Chromatin/Epigenetic
Purity
0.9974
Bioactivity
Revumenib (SNDX-5613) is a potent and selective oral inhibitor of menin-KMT2A interaction with Ki of 0.149 nM and IC50 between 10 and 20 nM, which can be used in the study of acute leukemia with MLL gene rearrangement.
Smiles
CCN(C(C)C)C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(C1)CCN(C[C@H]1CC[C@@H](CC1)NS(=O)(=O)CC)CC2
Molecular Formula
C32H47FN6O4S
Molecular Weight
630.82
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15156780 1 Vial
Lentiviral human UBE2W shRNA (UAS) - Lentiviral human UBE2W shRNA (UAS, RFP) (100)
Ask
View Details 
MBS2026321-01 0.1 mL
Polyclonal Antibody to Regenerating Islet Derived Protein 3 Beta (REG3b)
Ask
View Details MBS2026321-02 0.2 mL
Polyclonal Antibody to Regenerating Islet Derived Protein 3 Beta (REG3b)
Ask
View Details MBS2026321-03 0.5 mL
Polyclonal Antibody to Regenerating Islet Derived Protein 3 Beta (REG3b)
Ask
View Details 
MBS2026321-04 1 mL
Polyclonal Antibody to Regenerating Islet Derived Protein 3 Beta (REG3b)
Ask
View Details 
MBS2026321-05 5 mL
Polyclonal Antibody to Regenerating Islet Derived Protein 3 Beta (REG3b)
Ask
View Details